120 related articles for article (PubMed ID: 10731049)
41. Effect of selenite on renal toxicity and antitumor activity of cis-diamminedichloroplatinum in mice inoculated with Ehrlich ascites tumor cell.
Naganuma A; Satoh M; Imura N
J Pharmacobiodyn; 1984 Mar; 7(3):217-20. PubMed ID: 6540302
[TBL] [Abstract][Full Text] [Related]
42. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
Kim DK; Kim HT; Cho YB; Kim TS; Kim KH; Hong WS
Anticancer Res; 1996; 16(1):251-6. PubMed ID: 8615617
[TBL] [Abstract][Full Text] [Related]
43. Disposition kinetics of taxanes after intraperitoneal administration in rats and influence of surfactant vehicles.
Yokogawa K; Jin M; Furui N; Yamazaki M; Yoshihara H; Nomura M; Furukawa H; Ishizaki J; Fushida S; Miwa K; Miyamoto K
J Pharm Pharmacol; 2004 May; 56(5):629-34. PubMed ID: 15142340
[TBL] [Abstract][Full Text] [Related]
44. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
Liu J; Kraut EH; Balcerzak S; Grever M; D'Ambrosio S; Chan KK
Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470
[TBL] [Abstract][Full Text] [Related]
45. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
[TBL] [Abstract][Full Text] [Related]
46. The aqueous extract of cinnamon bark ameliorated cisplatin-induced cytotoxicity in vero cells without compromising the anticancer efficiency of cisplatin.
ElKady AI; Ramadan WS
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):363-71. PubMed ID: 27465514
[TBL] [Abstract][Full Text] [Related]
47. [The effect of zinc glycyrrhizate on toxicity and anticancer activity of cisplatin in mice].
Xu ZL; Guo JH; Song ST; Li MJ; Wu DZ
Yao Xue Xue Bao; 1993; 28(8):567-71. PubMed ID: 8285063
[TBL] [Abstract][Full Text] [Related]
48. Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
Fujimoto S
Biol Pharm Bull; 2006 Nov; 29(11):2260-6. PubMed ID: 17077525
[TBL] [Abstract][Full Text] [Related]
49. Intestinal toxicity evaluation of long-circulating and pH-sensitive liposomes loaded with cisplatin.
Araújo RS; Silveira ALM; de Sales E Souza ÉL; Freire RH; de Souza CM; Reis DC; Costa BRC; Sugimoto MA; Silveira JN; Dos Santos Martins F; Cassali GD; Leite JIA; Sousa LP; Ferreira AVM; Oliveira MC; Cardoso VN
Eur J Pharm Sci; 2017 Aug; 106():142-151. PubMed ID: 28546107
[TBL] [Abstract][Full Text] [Related]
50. Pharmacology and toxicology of Cremophor EL diluent.
Dorr RT
Ann Pharmacother; 1994 May; 28(5 Suppl):S11-4. PubMed ID: 7915152
[No Abstract] [Full Text] [Related]
51. Attenuating the toxicity of cisplatin by using selenosulfate with reduced risk of selenium toxicity as compared with selenite.
Zhang J; Peng D; Lu H; Liu Q
Toxicol Appl Pharmacol; 2008 Feb; 226(3):251-9. PubMed ID: 17950769
[TBL] [Abstract][Full Text] [Related]
52. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
53. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama N; Okazaki S; Cabral H; Miyamoto M; Kato Y; Sugiyama Y; Nishio K; Matsumura Y; Kataoka K
Cancer Res; 2003 Dec; 63(24):8977-83. PubMed ID: 14695216
[TBL] [Abstract][Full Text] [Related]
54. A population analysis of the pharmacokinetics of Cremophor EL using nonlinear mixed-effect modelling.
van den Bongard HJ; Mathôt RA; van Tellingen O; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2002 Jul; 50(1):16-24. PubMed ID: 12111107
[TBL] [Abstract][Full Text] [Related]
55. Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153.
Gately DP; Sharma A; Christen RD; Howell SB
Br J Cancer; 1996 Jan; 73(1):18-23. PubMed ID: 8554977
[TBL] [Abstract][Full Text] [Related]
56. Pentoxifylline potentiates the antitumor effect of cisplatin and etoposide on human lung cancer cell lines.
Ohsaki Y; Ishida S; Fujikane T; Kikuchi K
Oncology; 1996; 53(4):327-33. PubMed ID: 8692539
[TBL] [Abstract][Full Text] [Related]
57. Prevention of cisplatin-induced nephrotoxicity by methimazole.
Osman AM; El-Sayed EM; El-Demerdash E; Al-Hyder A; El-Didi M; Attia AS; Hamada FM
Pharmacol Res; 2000 Jan; 41(1):115-21. PubMed ID: 10600279
[TBL] [Abstract][Full Text] [Related]
58. Effect of copper pretreatment on toxicity and antitumor activity of cis-diamminedichloroplatinum in mice.
Naganuma A; Satoh M; Imura N
Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):265-74. PubMed ID: 6542689
[TBL] [Abstract][Full Text] [Related]
59. Improvement of intraperitoneal chemotherapy for rat ovarian cancer using cisplatin-containing microspheres.
Kumagai S; Sugiyama T; Nishida T; Ushijima K; Yakushiji M
Jpn J Cancer Res; 1996 Apr; 87(4):412-7. PubMed ID: 8641974
[TBL] [Abstract][Full Text] [Related]
60. Mechanism of the protective effect of sodium malate on cisplatin-induced toxicity in mice.
Ueda H; Sugiyama K; Tashiro S; Yokota M
Biol Pharm Bull; 1998 Feb; 21(2):121-8. PubMed ID: 9514605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
